• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business

    1/9/25 9:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email

    New leadership role reflects Centene's focus on ICHRA growth

    ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan that works best for them, using a tax-free stipend from their employer.

    Alan Silver announced as Centene's President, ICHRA (Individual Coverage Health Reimbursement Arrangements).

    "We believe ICHRA is the future of healthcare coverage for individuals and families, increasing flexibility and affordability," said Centene Chief Executive Officer Sarah London. "Combining our experience supporting the coverage needs of hard-working Americans with Alan's industry-leading ICHRA expertise will accelerate our work to foster greater adoption of ICHRA as a strategic and innovative solution for employers and employees alike."

    Silver will bring more than two decades of leadership experience in benefits administration and actuarial consulting to the role, including a proven record of driving growth, developing client-focused benefit solutions and pioneering exchange-based healthcare strategies.

    "Alan's appointment underscores our dedication to making ICHRA a cornerstone of our growth strategy," said Ambetter Health's Chief Executive Officer Kevin Counihan. "With his exceptional background in benefits innovation and deep understanding of the market, Alan is the ideal leader to advance our vision and help us set a high standard for ICHRA offerings, providing meaningful value to employers and employees across the nation."

    Most recently, Silver led retiree medical and ICHRA initiatives at Willis Towers Watson. His expertise uniquely positions him to lead Ambetter's efforts in expanding and enhancing ICHRA offerings to meet and drive evolving market needs.

    "I am excited to join Ambetter Health and Centene," said Silver. "ICHRA is an exciting opportunity to transform how employers provide healthcare benefits, and Centene is uniquely positioned to lead this evolution. I look forward to collaborating with the team to deliver innovative solutions that empower organizations and their employees."

    Ambetter serves more than 4.5 million members in the individual market, focusing on delivering reliable, high-quality healthcare benefits that adapt to the changing needs of its members and the market. Its approach to ICHRA is rooted in deep industry and product expertise to making healthcare better for all through choice and accessibility.

    For more information about Ambetter and its ICHRA solutions, visit https://www.ambetterhealth.com/en/employers/.

    About Centene Corporation

    Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

    Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.

    About Ambetter

    Ambetter Health is a health insurance offering that is available on the Health Insurance Marketplace, or Exchange, and available off-exchange in select states. It is one of the healthcare programs provided by Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. Ambetter Health is made available through local health plans and covers a wide variety of healthcare services, including preventive and wellness services, maternity and newborn care, pediatric services, mental health and substance misuse services, prescription drug coverage and more. To see Ambetter's Market Notice, please click here. For more information on health benefits and health insurance plans in your state, please visit the state specific link on AmbetterHealth.com.

     

    Centene Corporation Logo (PRNewsfoto/Centene Corporation)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/centene-corporation-names-first-president-over-individual-coverage-health-reimbursement-arrangements-ichra-business-302346988.html

    SOURCE Centene Corporation

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief People Officer Mcnally Tanya M was granted 74,311 shares, increasing direct ownership by 131% to 131,007 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:13 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Corporate Controller & CAO Casso Katie was granted 26,036 shares, increasing direct ownership by 30% to 113,135 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:20 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Chief Operating Officer Smith Susan Raye was granted 112,823 shares, increasing direct ownership by 110% to 215,638 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:08 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    South L.A. Residents Gain 37 New Affordable Homes as Eleos and Health Net Break Ground at 5637 S. Broadway

    New development adds long-term housing stability for low-income households in South Los AngelesLOS ANGELES, March 4, 2026 /PRNewswire/ -- More South Los Angeles residents will soon have a stable place to call home. Today, Eleos and Health Net marked the start of construction on a new 37-unit affordable housing community at 5637 S. Broadway in South Los Angeles. The project was made possible in part by a $550K investment from Health Net, which helped close the remaining funding gap and advance construction of the 100% affordable development. This is a 100% affordable development

    3/4/26 9:57:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    More than 900 California Families to Find Housing Stability in 2026 Thanks to $31.25 Million Investment by Health Net

    Ten new housing projects across four counties will provide at least 900 new affordable housing units, improving health outcomes, providing secure living environments and reducing pressure on emergency servicesLOS ANGELES, March 3, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), announced today it awarded $31.25 million in grants to develop 10 distinct housing investments in Los Angeles, Sacramento, San Joaquin and Stanislaus counties. The funding represents 84% of the company'

    3/3/26 11:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Superior HealthPlan Accepting Applications for $100,000 in Grants Through Annual Program

    Community-based organizations in Texas can apply for $10,000 grants by March 31, 2026.AUSTIN, Texas, March 3, 2026 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE:CNC), is accepting applications for its annual grant program. The funding will help address non-medical drivers of health, also known as social determinants of health, to meet the needs of low-income neighborhoods throughout Texas. "This grant program reflects Superior's long-standing commitment to supporting organizations that ad

    3/3/26 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CENTENE CORP (0001071739) (Filer)

    2/20/26 9:32:27 PM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Centene Corporation

    10-K - CENTENE CORP (0001071739) (Filer)

    2/17/26 4:31:45 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    2/5/26 8:52:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Centene upgraded by Barclays with a new price target

    Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00

    1/5/26 8:29:16 AM ET
    $CNC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Centene with a new price target

    Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00

    10/14/25 8:47:32 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under

    1/13/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

    -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

    10/29/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care